Modulation of the Specificity of Carbapenems and Diazabicyclooctanes for Selective Activity against Mycobacterium tuberculosis.

MLA

Barnier, Jean-Philippe, et al. “Modulation of the Specificity of Carbapenems and Diazabicyclooctanes for Selective Activity against Mycobacterium Tuberculosis.” Antimicrobial Agents and Chemotherapy, vol. 66, no. 9, Sept. 2022, p. e0235721. EBSCOhost, https://doi.org/10.1128/aac.02357-21.

APA

Barnier, J.-P., Saidjalolov, S., Bouchet, F., Mayer, L., Edoo, Z., Sayah, I., Iannazzo, L., Ethève-Quelquejeu, M., Mainardi, J.-L., Braud, E., & Arthur, M. (2022). Modulation of the Specificity of Carbapenems and Diazabicyclooctanes for Selective Activity against Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 66(9), e0235721. https://doi.org/10.1128/aac.02357-21

Chicago

Barnier, Jean-Philippe, Saidbakhrom Saidjalolov, Flavie Bouchet, Louis Mayer, Zainab Edoo, Inès Sayah, Laura Iannazzo, et al. 2022. “Modulation of the Specificity of Carbapenems and Diazabicyclooctanes for Selective Activity against Mycobacterium Tuberculosis.” Antimicrobial Agents and Chemotherapy 66 (9): e0235721. doi:10.1128/aac.02357-21.